Covered recipient · General Payments record
ANGELA MARIE EMERSON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$892.24
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $260.28 | 3 |
| Food and Beverage | $237.56 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $160.29 | 2 |
| Coherus Biosciences Inc. | $146.70 | 3 |
| SEAGEN INC. | $99.99 | 1 |
| Acerta Pharma LLC | $48.09 | 2 |
| Alexion Pharmaceuticals, Inc. | $26.87 | 1 |
| GENZYME CORPORATION | $15.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $26.87 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093942810 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.07 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104689242 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.02 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104594140 | CMS |
| Coherus Biosciences Inc. | $64.96 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147276190 | CMS |
| Coherus Biosciences Inc. | $15.29 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147276192 | CMS |
| Coherus Biosciences Inc. | $66.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147276248 | CMS |
| GENZYME CORPORATION | $15.90 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139996933 | CMS |
| Lilly USA, LLC | $48.36 | 08/08/2024 | Education | Undisputed | 01/23/2026 | 1135533610 | CMS |
| Lilly USA, LLC | $111.93 | 09/19/2024 | Education | Undisputed | 01/23/2026 | 1135533614 | CMS |
| SEAGEN INC. | $99.99 | 09/18/2024 | Education | Undisputed | 01/23/2026 | 1130894694 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.